Join
Live feed
·
INSIDERFilingvia Quantisnow
Seres Therapeutics Inc. logo

Officer Henn Matthew R. converted options into 10,626 shares and sold $3,204 worth of shares (3,953 units at $0.81), increasing direct ownership by 9% to 84,443 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track MCRB (Seres Therapeutics Inc.) and more on Quantisnow.